Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of a Caffeine Blend on Reaction Time, Mental Performance and Focus in Athletic Males

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03019523
Recruitment Status : Completed
First Posted : January 12, 2017
Last Update Posted : January 25, 2017
Sponsor:
Collaborator:
NBTY, Inc.
Information provided by (Responsible Party):
Lemuel W. Taylor IV, University of Mary Hardin-Baylor

Brief Summary:
This is a cross-over design study in which subjects arrived to the lab and were assigned a supplement to ingest. Prior to ingestion subjects completed baseline reaction time testing along with a questionnaire. Thirty minutes after ingestion subjects filled out the same questionnaire, completed a reaction time test, followed by a series of dynamic exercises. After the last exercise was finished subjects filled out the questionnaire, completed another reaction time test and repeated the series of dynamic exercises. Following the exercises, subjects filled out the questionnaire and completed a fourth round of reaction time testing. In total subjects would complete 2 rounds of dynamic exercises and 4 rounds of reaction time testing with heart rate being recorded before and after the dynamic exercise rounds. Subjects were told to wash-out for 7 days and return to the lab to complete the same testing but on the alternative supplement.

Condition or disease Intervention/treatment Phase
Mental Fatigue Dietary Supplement: Caffeine Blend Other: Sugar Pill Not Applicable

Detailed Description:

Subjects expressing interest in doing the study, were interviewed in the Human Performance Lab (HPL) to determine whether they appear to qualify to participate in the study. Qualifying subjects, were then invited back to the HPL for an entry/familiarization session and be verbally told all of the requirements of the study. During this session, subjects signed Informed Consent Statements and completed personal and medical history questionnaires. Subject were familiarized to the study protocol via a verbal and written explanation outlining the study design. This included describing the testing sessions to the subjects about the tests to be performed including the Makoto testing system (reaction time testing). Subjects practiced several times during this session to eliminate the learning curve of using new equipment. Subjects were also taken through 1 round of the dynamic exercises to ensure ability to complete each exercise as needed. Subjects were then given an appointment time to perform qualifying Makoto testing to achieve greater than or equal to 70% accuracy on 3 towers at a level 7 for three consecutive trails.

Following the practice session, subjects recorded all food intake via MyFitnessPal for three days (3-d) prior to baseline testing. Subjects were instructed to refrain from exercise, caffeine, and alcohol the day prior to baseline testing and to consume their normal breakfast the morning of testing. Subjects were given a meal replacement bar in place of lunch, to consume ~2 hours before their testing session. During this time, subjects had body composition and hemodynamic assessments recorded. Two hours after ingestion of meal bar subjects reported back to the HPL and completed a Visual Analog Scale (VAS) questionnaire, a baseline Makoto prior to ingesting their assigned supplement. Thirty minutes after ingestion, Makoto and dynamic exercisers were completed. This involved subjects doing a standardized full body workout in 2 different rounds of exercise. After each round of exercise subjects filled out the VAS and performed Makoto testing. Subject then were instructed to wash-out and were scheduled for their 2nd testing session ~7 days later.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 31 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Other
Official Title: Effects Of A Proprietary Supplement On The Acute Responses In Reaction Time, Mental Performance, And Indicators Of Focus In Athletic Populations
Study Start Date : August 2016
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Placebo Comparator: Sugar Pill
Maltodextrin (~2 grams to match weight of active treatment) placebo pre-testing (1 dose w/3 oz of water) 30 minutes following ingestion exercise and Makoto testing were completed.
Other: Sugar Pill
Taken orally in capsule form

Active Comparator: Caffeine Blend
75 mg caffeine, 75 mg theanine, and 2g tyrosine pre-testing (1 dose w/3 oz of water) 30 minutes following ingestion exercise and Makoto testing were completed.
Dietary Supplement: Caffeine Blend
Taken orally in capsule form




Primary Outcome Measures :
  1. Response to Caffeine on Measures of Reaction Time by Makoto [ Time Frame: up to 4 hours ]
    The primary purpose of this investigation is to determine if acute ingestion of a proprietary supplement containing caffeine, theanine, and tyrosine has any positive effects on markers of reaction time in athletic populations.

  2. Response to Caffeine on Measures of Mental Performance by Survey in Athletic Populatons [ Time Frame: up to 4 hours ]
    The primary purpose of this investigation is to determine if acute ingestion of a proprietary supplement containing caffeine, theanine, and tyrosine has any positive effects on markers of mental performance in athletic populations.

  3. Response to Caffeine on Measures of Cognitive Fatigue by Survey in Athletic Populatons [ Time Frame: up to 4 hours ]
    The primary purpose of this investigation is to determine if acute ingestion of a proprietary supplement containing caffeine, theanine, and tyrosine has any positive effects on markers of cognitive fatigue in athletic populations.


Secondary Outcome Measures :
  1. Response to Caffeine on Measures of Physical Performance by Comparing the Total Amount of Work Completed [ Time Frame: up to 4 hours ]
    The secondary purpose of this investigation is to determine if acute ingestion of a proprietary supplement containing caffeine, theanine, and tyrosine has any positive effects on markers of physical performance in athletic populations.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 25 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria

  • Subjects will be males between the ages of 18-25 years
  • Subjects will be team sport athletes or highly trained
  • Subjects will not be able to smoke or use tobacco
  • Subjects has provided written and dated informed consent to participate in the study
  • Subjects is willing and able to comply with the protocol
  • Subjects is apparently healthy and free from disease, as determined by a health history questionnaire
  • Subjects is a regular caffeine consumer (up to 2 cups of coffee a day)
  • Subjects agrees to abstain from caffeine the day of each testing session
  • Subjects agrees to abstain from exercise 24 hours prior to each testing visit. 48 hours prior to the testing session, the subject should not do anything new or unaccustomed in the form of exercise and should not increase the intensity of their workouts.

Subject Exclusion Criteria

  • Subject has not been participating in regular physical activity and exercise trained for at least 12 months prior to enrollment
  • Subject is diagnosed with any metabolic or chronic disease, or is on prescription medication for the diagnosed metabolic or chronic disease
  • Subject is using, or has used a dietary supplement (other than a multi-vitamin/-mineral, protein powder, or meal replacements) within 6 weeks prior to enrollment. Protein/Meal Replacement Products (MRPs) must not contain any supplements such as creatine, beta-alanine, hydroxyl methlybutyrate (HMB), etc.
  • Subject is in, or has participated in another clinical trial within 8 weeks prior to enrollment
  • Subject has a known allergy or sensitivity to caffeine or other stimulants (determined from health history questionnaire.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03019523


Locations
Layout table for location information
United States, Texas
UMHB Human Performance Lab
Belton, Texas, United States, 76513
Sponsors and Collaborators
University of Mary Hardin-Baylor
NBTY, Inc.
Investigators
Layout table for investigator information
Principal Investigator: Lemuel W Taylor, PhD UMHB Human Performance Lab

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Lemuel W. Taylor IV, Director, Exercise Biochemistry Laboratory, University of Mary Hardin-Baylor
ClinicalTrials.gov Identifier: NCT03019523     History of Changes
Other Study ID Numbers: NBTY-1
First Posted: January 12, 2017    Key Record Dates
Last Update Posted: January 25, 2017
Last Verified: January 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Lemuel W. Taylor IV, University of Mary Hardin-Baylor:
caffeine
mental performance
reaction time
focus
Additional relevant MeSH terms:
Layout table for MeSH terms
Fatigue
Mental Fatigue
Signs and Symptoms
Behavioral Symptoms
Caffeine
Central Nervous System Stimulants
Physiological Effects of Drugs
Phosphodiesterase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Purinergic P1 Receptor Antagonists
Purinergic Antagonists
Purinergic Agents
Neurotransmitter Agents